Peringkat dalam Saham
#39158
H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated... H-CYTE, Inc. is a biopharmaceutical firm based in the United States, dedicated to developing and supplying a range of treatments for individuals afflicted with persistent respiratory and pulmonary diseases. The company's core strategy involves pioneering and deploying autologous cellular therapy solutions specifically for chronic lung conditions. Additionally, H-CYTE maintains a product supply agreement with Rion, LLC, focused on advancing and distributing a biologic compound designed to combat chronic obstructive pulmonary disease (COPD). Its corporate headquarters are situated in Tampa, Florida.
Harga Saham
$0.995
Terakhir disinkronkan: 2023-07-07
Kapitalisasi Pasar
$624.98K
Perubahan (1 hari)
-0.50%
Perubahan (1 tahun)
0.00%
Perdagangan H-CYTE, Inc. (HCYT)
Harga HCYT dengan kapitalisasi pasar B
Kapitalisasi pasar dari H-CYTE, Inc.(HCYT)
Kapitalisasi Pasar: $624.98K
Per August 2026, H-CYTE, Inc. memiliki kapitalisasi pasar sebesar $624.98K. Ini menjadikan H-CYTE, Inc. sebagai perusahaan 39158th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar H-CYTE, Inc. dari 2014 hingga 2026
HCYT dibandingkan dengan 5 teratas stocks paling populer
| Harga HCYT |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+875,154,789.59%
|
|
|
|
|
$4.467T
|
+714,754,850.85%
|
|
|
|
|
$4.174T
|
+667,923,733.40%
|
|
|
|
|
$3.700T
|
+592,031,782.89%
|
|
|
|
|
$2.854T
|
+456,709,785.08%
|
